Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas

[1] Alberts SR(2003)Gastric cancer: epidemiology, pathology and treatment Ann Oncol 14 ii31-ii36

[2] Cervantes A(2009)microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells Clin Cancer Res 15 2281-2290

[3] van de Velde CJ(2003)DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism Neurol Sci 24 159-160

[4] Bandres E(2008)The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer Pathol Oncol Res 14 79-83

[5] Bitarte N(2011)Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer Tissue Antigen 78 120-128

[6] Arias F(1991)CEA in tumors of other than colorectal origin Semin Surg Oncol 7 162-166

[7] Agorreta J(2010)Upregulation of plasma C9 protein in gastric cancer patients Proteomics 10 3210-3221

[8] Fortes P(2011)Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays PLoS One 6 e14540-1704

[9] Agirre X(2005)Overexpression of cathepsin B in gastric cancer identified by proteome analysis Proteomics 5 1693-590

[10] Zarate R(2005)Identification of the thrombin light chain a as the single best mass for differentiation of gastric cancer patients from individuals with dyspepsia by proteome analysis J Proteome Res 4 586-2158

[1] Alberts SR(2003)Gastric cancer: epidemiology, pathology and treatment Ann Oncol 14 ii31-ii36

[2] Cervantes A(2009)microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells Clin Cancer Res 15 2281-2290

[3] van de Velde CJ(2003)DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism Neurol Sci 24 159-160

[4] Bandres E(2008)The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer Pathol Oncol Res 14 79-83

[5] Bitarte N(2011)Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer Tissue Antigen 78 120-128

[6] Arias F(1991)CEA in tumors of other than colorectal origin Semin Surg Oncol 7 162-166

[7] Agorreta J(2010)Upregulation of plasma C9 protein in gastric cancer patients Proteomics 10 3210-3221

[8] Fortes P(2011)Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays PLoS One 6 e14540-1704

[9] Agirre X(2005)Overexpression of cathepsin B in gastric cancer identified by proteome analysis Proteomics 5 1693-590

[10] Zarate R(2005)Identification of the thrombin light chain a as the single best mass for differentiation of gastric cancer patients from individuals with dyspepsia by proteome analysis J Proteome Res 4 586-2158